NeueHealth
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 281m | 1.2b | 4.0b | 2.4b | 1.2b | 1.0b | 1.1b |
% growth | 115 % | 330 % | 234 % | (40 %) | (52 %) | (13 %) | 13 % |
EBITDA | (124m) | (249m) | (1.2b) | (425m) | (8.5m) | 26.0m | 38.4m |
% EBITDA margin | (44 %) | (21 %) | (29 %) | (18 %) | (1 %) | 3 % | 3 % |
Profit | (125m) | (248m) | (1.2b) | (1.5b) | (347m) | (37.1m) | (39.4m) |
% profit margin | (45 %) | (21 %) | (29 %) | (60 %) | (30 %) | (4 %) | (3 %) |
EV / revenue | - | - | 0.3x | 0.1x | 0.3x | -0.2x | 0.0x |
EV / EBITDA | - | - | -0.9x | -0.6x | -39.8x | -7.4x | 1.1x |
R&D budget | 7.2m | 19.4m | 2.5m | 2.5m | - | - | - |
R&D % of revenue | 3 % | 2 % | - | - | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$80.0m | Series A | ||
* | €146m | Series B | |
* | $200m Valuation: $950m | Series C | |
* | $635m | Series D | |
$500m Valuation: $3.2b 11.3x EV/LTM Revenues -25.6x EV/LTM EBITDA | Series E | ||
N/A | $924m Valuation: $11.2b 9.3x EV/LTM Revenues -45.0x EV/LTM EBITDA | IPO | |
* | $750m | Post IPO Equity | |
* | N/A | $175m | Post IPO Convertible |
* | $60.0m | Post IPO Debt | |
* | $30.0m | Post IPO Debt | |
Total Funding | $1.6b |
Recent News about NeueHealth
EditNeueHealth is a forward-thinking company dedicated to transforming the healthcare industry by making care more personal, affordable, and efficient. The company operates in the value-based care market, which focuses on improving patient outcomes while reducing costs. This approach contrasts with the traditional volume-based care model that prioritizes the number of services provided over the quality of care.
NeueHealth serves a diverse range of clients, including healthcare providers (doctors, clinics, hospitals) and payors (insurance companies). The company enables providers to excel in value-based care by offering a suite of services designed to enhance clinical performance and streamline administrative processes. These services include Care Management, Population Health Management, and Utilization Management, all of which aim to improve patient care and operational efficiency.
One of NeueHealth's key offerings is its next-generation administrative services. The company has modernized traditional back-office functions to reduce complexity and improve efficiency. This includes claims administration, delegation oversight, and risk adjustment programs. By handling these administrative tasks, NeueHealth allows healthcare providers to focus more on patient care and less on paperwork.
NeueHealth also leverages advanced population health technology to provide cutting-edge analytics and insights. This technology helps care teams make informed decisions at the right time, ultimately driving better quality, cost, and efficiency in healthcare delivery.
The company makes money through a transparent partnership model, where it collaborates closely with providers and payors. By connecting high-performing providers with payors who are excelling under risk-based payment models, NeueHealth ensures that all parties benefit from improved care quality and cost savings.
In summary, NeueHealth is at the forefront of the shift to value-based care, offering innovative solutions that benefit providers, payors, and patients alike.
Keywords: value-based care, healthcare providers, payors, clinical performance, care management, population health, administrative services, risk adjustment, healthcare technology, cost efficiency.